Clinical Trial Update: Evaluation of Biodentine and Mineral Trioxide Aggregate in Revascularization of Non Vital Immature Anterior Teeth [NA]

View source ↗

Summary

This clinical trial evaluated Biodentine and ProRoot Mineral Trioxide Aggregate for revascularization of non-vital immature anterior teeth and the study is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulp Necrosis

Drugs mentioned

• Biodentine (tricalcium silicate cement)
• ProRoot MTA (mineral trioxide aggregate)

Snippet

Sponsor: Cairo University | Conditions: Pulp Necrosis | NA | Status: COMPLETED